A xenograft model of infant leukaemia reveals a complex MLL translocation

British Journal of Haematology

Volumn 140, Issue 6, 2008, Pages 716-719

  Henderson, Michelle J ^a   Choi, Seoyeon ^a   Beesley, Alex H ^b   Baker, David L ^c   Wright, Dale ^d   Papa, Rachael A ^a   Murch, Ashleigh ^e   Campbell, Lynda J ^f   Lock, Richard B ^a   Norris, Murray D ^a   Haber, Michelle ^a   Kees, Ursula R ^b  

^a CHILDREN S CANCER INSTITUTE AUSTRALIA FOR MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^d Sydney Genetics   (Australia)

^e KING EDWARD MEMORIAL HOSPITAL   (Australia)

^f ST VINCENT S HOSPITAL   (Australia)

Author keywords

Acute leukaemia; MLL; MLLT1; Translocation; Xenograft model

Indexed keywords

ASPARAGINASE; DAUNORUBICIN; MIXED LINEAGE LEUKEMIA PROTEIN; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; CASE REPORT; CHROMOSOME 11Q; CHROMOSOME 13; CHROMOSOME 19; CHROMOSOME 2; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INFANT; KARYOTYPING; LETTER; LEUKEMIA CELL; LEUKEMIA REMISSION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; SCID MOUSE; XENOGRAFT;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFANT; KARYOTYPING; MICE; MICE, SCID; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASM TRANSPLANTATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSLOCATION, GENETIC; TRANSPLANTATION, HETEROLOGOUS;

EID: 39749171384     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06966.x     Document Type: Letter

References (9)

1. Kosaka, Y., Koh, K., Kinukawa, N., Wakazono, Y., Isoyama, K., Oda, T., Hayashi, Y., Ohta, S., Moritake, H., Oda, M., Nagatoshi, Y., Kigasawa, H., Ishida, Y., Ohara, A., Hanada, R., Sako, M., Sato, T., Mizutani, S., Horibe, K. Ishii, E. (2004) Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation. Blood, 104, 3527 3534.
2. Liem, N.L., Papa, R.A., Milross, C.G., Schmid, M.A., Tajbakhsh, M., Choi, S., Ramirez, C.D., Rice, A.M., Haber, M., Norris, M.D., MacKenzie, K.L. Lock, R.B. (2004) Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies. Blood, 103, 3905 3914.
3. Meyer, C., Schneider, B., Jakob, S., Strehl, S., Attarbaschi, A., Schnittger, S., Schoch, C., Jansen, M.W., van Dongen, J.J., den Boer, M.L., Pieters, R., Ennas, M.G., Angelucci, E., Koehl, U., Greil, J., Griesinger, F., Zur Stadt, U., Eckert, C., Szczepanski, T., Niggli, F.K., Schafer, B.W., Kempski, H., Brady, H.J., Zuna, J., Trka, J., Nigro, L.L., Biondi, A., Delabesse, E., Macintyre, E., Stanulla, M., Schrappe, M., Haas, O.A., Burmeister, T., Dingermann, T., Klingebiel, T. Marschalek, R. (2006) The MLL recombinome of acute leukemias. Leukemia, 20, 777 784.
4. Nachman, J.B., Sather, H.N., Sensel, M.G., Trigg, M.E., Cherlow, J.M., Lukens, J.N., Wolff, L., Uckun, F.M. Gaynon, P.S. (1998) Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. New England Journal of Medicine, 338, 1663 1671.
5. Pieters, R., Schrappe, M., De Lorenzo, P., Hann, I., De Rossi, G., Felice, M., Hovi, L., LeBlanc, T., Szczepanski, T., Ferster, A., Janka, G., Rubnitz, J., Silverman, L., Stary, J., Campbell, M., Li, C.K., Mann, G., Suppiah, R., Biondi, A., Vora, A. Valsecchi, M.G. (2007) A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet, 370, 240 250.
6. Pocock, C.F., Malone, M., Booth, M., Evans, M., Morgan, G., Greil, J. Cotter, F.E. (1995) BCL-2 expression by leukaemic blasts in a SCID mouse model of biphenotypic leukaemia associated with the t(4;11)(q21;q23) translocation. British Journal of Haematology, 90, 855 867.
7. Pui, C.H., Chessells, J.M., Camitta, B., Baruchel, A., Biondi, A., Boyett, J.M., Carroll, A., Eden, O.B., Evans, W.E., Gadner, H., Harbott, J., Harms, D.O., Harrison, C.J., Harrison, P.L., Heerema, N., Janka-Schaub, G., Kamps, W., Masera, G., Pullen, J., Raimondi, S.C., Richards, S., Riehm, H., Sallan, S., Sather, H., Shuster, J., Silverman, L.B., Valsecchi, M.G., Vilmer, E., Zhou, Y., Gaynon, P.S. Schrappe, M. (2003) Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia, 17, 700 706.
8. Steinherz, P.G., Redner, A., Steinherz, L., Meyers, P., Tan, C. Heller, G. (1993) Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol. Cancer, 72, 3120 3130.
9. Uckun, F.M., Waurzyniak, B.J., Sensel, M.G., Chelstrom, L., Crotty, M.L., Gaynon, P.S. Reaman, G.H. (1998) Primary blasts from infants with acute lymphoblastic leukemia cause overt leukemia in SCID mice. Leukemia & Lymphoma, 30, 269 277.